More SEC Filings
View Older Stories View Newer Stories-
Form 4 SPAR Group, Inc. For: Jan 28 Filed by: BROWN ROBERT G/
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 13F-HR/A Bordeaux Wealth Advisors For: Dec 31
-
Form 13F-HR Myriad Asset Management For: Dec 31
-
Form 15-12G Coliseum Acquisition
-
Form C/A Butcher's Fund Inc.
-
Form 424B2 CITIGROUP INC
-
Form 10-D Bank of America Merrill For: Jan 17
-
Form 424B2 BARCLAYS BANK PLC
-
Form 497K VanEck ETF Trust
-
Form 424B2 BARCLAYS BANK PLC
-
Form 4 Apellis Pharmaceuticals, For: Jan 29 Filed by: Watson David O.
-
Form S-6 m funds Trust
-
Form 497K VanEck ETF Trust
-
Form 497K VanEck ETF Trust
-
Form D Next Level Ventures Fund
-
Form 3 PYXUS INTERNATIONAL, For: Jan 28 Filed by: BARCLAYS PLC
-
Form 497 VARIABLE SEPARATE ACCOUN
-
Form 4 Apellis Pharmaceuticals, For: Jan 29 Filed by: Townsend Adam J.
-
Form 424B2 CITIGROUP INC
-
Form 10-D Benchmark 2021-B28 Mortg For: Jan 17
-
Form 497J X-SQUARE SERIES TRUST
-
Form 497 VARIABLE SEPARATE ACCOUN
-
Form 10-D BANK 2020-BNK30 For: Jan 17
-
Form ABS-15G VISIO 2023-2 DEPOSITOR For: Dec 31
-
Form 497K VanEck ETF Trust
-
Form ABS-EE Benchmark 2021-B28 Mortg For: Jan 17
-
Form 4 Apellis Pharmaceuticals, For: Jan 29 Filed by: Sullivan Timothy Eugene
-
Form D Moncayo Club LLC
-
Form 424B2 HSBC USA INC /MD/
-
Form ABS-EE BANK 2020-BNK30 For: Jan 17
-
Form 10-D Benchmark 2022-B36 Mortg For: Jan 17
-
Form 487 FT 11974
-
Form 10-D JPMBB Commercial Mortgag For: Jan 17
-
Form 497K VanEck ETF Trust
-
Form ABS-15G VISIO 2023-1 DEPOSITOR For: Dec 31
-
Form 10-D Morgan Stanley Bank of For: Jan 17
-
Form 487 FT 12060
-
Form D/A Valence8 Diversified
-
Form 4 Apellis Pharmaceuticals, For: Jan 29 Filed by: Nicholson Nur
-
Form 144 IBEX Ltd Filed by: Allibhoy Khaishgi Family Foundation
-
Form 497 VARIABLE SEPARATE ACCOUN
-
Form 8-K TRANSUITE.ORG INC. For: Jan 30
-
Form ABS-EE Benchmark 2022-B36 Mortg For: Jan 17
-
Form 497K VanEck ETF Trust
-
Form 487 FT 11943
-
Form 497K VanEck ETF Trust
-
Form 487 FT 11992
-
Form ABS-EE Morgan Stanley Bank of For: Jan 17
-
Form 4 Apellis Pharmaceuticals, For: Jan 29 Filed by: Lewis Karen

